Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Yiannis Zourmpanos

Anthropic Just Made a CRISPR-Like Discovery. What It Actually Means for CRSP Stock Investors.

Artificial intelligence is starting to transition from being software to becoming a means of scientific discovery, and the latter development did not go unnoticed in the biotech market sector last week. Shares of CRISPR Therapeutics (CRSP) fell after Anthropic revealed that its Claude AI model had independently discovered a new uncharacterized enzyme system that shows certain similarities to CRISPR.

Anthropic stated that Claude independently analyzed an extensive database of DNA sequences and discovered what it called array-associated reverse transcriptases, or ARTs. Notably, scientists still do not know what the primary function of the system is. Anthropic stated that further experiments are being carried out.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.